Literature DB >> 16197660

Overactive bladder in women: symptom impact and treatment expectations.

Scott MacDiarmid1, Matt Rosenberg.   

Abstract

OBJECTIVE: The objectives of this survey were to understand (1) the effects of overactive bladder (OAB) and urinary incontinence (UI) on women's lives and to understand (2) women's needs and expectations of health care providers and treatment related to these disorders.
METHODS: Women (N = 1046) with self-reported symptoms of UI completed a survey via electronic mail about the impact of urinary symptoms, health care provider interactions, treatment practices and expectations, and co-morbid conditions.
RESULTS: The majority of women rated urinary symptoms such as frequency (61%), urgency (80%), nocturia (72%), and UI (69%-88% by type of incontinence) as moderately or extremely bothersome. Over half of women with UI (55%) had not sought medical treatment, but instead used a variety of non-medical coping mechanisms for symptom management. More than one third of women (37%) would prefer that their health care provider initiate discussion about urinary symptoms. Approximately half of the women with UI in this survey desired a greater than 70% reduction in incontinence episodes in order to consider treatment effective.
CONCLUSION: Women are making an effort to cope with disruptive symptoms of OAB. However, a communication gap between health care providers and patients with urinary symptoms may be a barrier to appropriate medical therapy. Health care providers should routinely query patients about urinary symptoms. In addition to choosing a medical treatment that can produce a meaningful reduction in symptoms, health care providers should set expectations for patients and monitor patient satisfaction with the prescribed treatment regimen.

Entities:  

Mesh:

Year:  2005        PMID: 16197660     DOI: 10.1185/030079905X59076

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  10 in total

1.  Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire.

Authors:  Linda Brubaker; Vik Khullar; Elisabeth Piault; Christopher J Evans; Tamara Bavendam; James Beach; Yating Yeh; Zoe S Kopp; Con J Kelleher; Jeffrey Trocio
Journal:  Int Urogynecol J       Date:  2011-03-04       Impact factor: 2.894

2.  Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women.

Authors:  Rebecca Rogers; Gloria Bachmann; Zhanna Jumadilova; Franklin Sun; Jon D Morrow; Zhonghong Guan; Tamara Bavendam
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-07

Review 3.  Nocturia: Current Evaluation and Treatment for Urology.

Authors:  Tony Nimeh; Pedro Alvarez; Naem Mufarreh; Lori B Lerner
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

4.  European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.

Authors:  Vik Khullar; Daniela Marschall-Kehrel; Montserrat Espuna-Pons; Con J Kelleher; Shannon E Tully; Elisabeth C Piault; Linda Brubaker; Aino Fianu-Jonasson; David Weinstein; Agneta Bergqvist; Marion Kvasz
Journal:  Int Urogynecol J       Date:  2013-04-09       Impact factor: 2.894

5.  "Seeing a doctor is just like having a date": a qualitative study on doctor shopping among overactive bladder patients in Hong Kong.

Authors:  Judy Yuen-Man Siu
Journal:  BMC Fam Pract       Date:  2014-02-06       Impact factor: 2.497

6.  The effect of nocturia on sleep quality and daytime function in patients with lower urinary tract symptoms: a cross-sectional study.

Authors:  I-Hung Shao; Chia-Chen Wu; Hueih-Shing Hsu; Shyh-Chyi Chang; Hsu-Hsiang Wang; Heng-Chang Chuang; Yuan-Yun Tam
Journal:  Clin Interv Aging       Date:  2016-06-29       Impact factor: 4.458

7.  Communicating with mismatch and tension: treatment provision experiences of primary care doctors treating patients with overactive bladder in Hong Kong.

Authors:  Judy Yuen-Man Siu
Journal:  BMC Fam Pract       Date:  2015-10-30       Impact factor: 2.497

Review 8.  Which drugs are best for overactive bladder? From patients' expectations to physicians' decisions.

Authors:  Ian Milsom; Adrian Wagg; Matthias Oelke; Christopher Chapple
Journal:  Int J Clin Pract       Date:  2020-12-11       Impact factor: 2.503

9.  What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine.

Authors:  Adrian S Wagg; Sender Herschorn; Martin Carlsson; Mireille Fernet; Matthias Oelke
Journal:  Neurourol Urodyn       Date:  2021-05-26       Impact factor: 2.367

Review 10.  A practical approach to the management of nocturia.

Authors:  Matthias Oelke; Stefan De Wachter; Marcus J Drake; Antonella Giannantoni; Mike Kirby; Susan Orme; Jonathan Rees; Philip van Kerrebroeck; Karel Everaert
Journal:  Int J Clin Pract       Date:  2017-10-05       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.